This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Sunesis Pharmaceuticals, Inc.
Drug Names(s): SNS-314
Description: SNS-314 is a targeted inhibitor of the Aurora A and B kinases.
Pink Sheet Weekly Trademark Review March 24, 2015
Additional information available to subscribers only: